News
MedBot® Performs World's First Robotic Cryoablation of Prostate Cancer - 01 Jan 2023
The world's first prostate cancer focal treatment using a prostate pos...MicroPort® MedBot® SkyWalker™ Orthopedic Surgical Robot Gets CE Marking - 31 Dec 2022
MicroPort® OrthoBot has recently obtained CE marking for SkyWalker™ Or...6 Endovastec™ Products Approved for Marketing in Belarus - 30 Dec 2022
Recently, 6 products independently developed by Endovastec™ have been ...TARGET IV-NA Clinical Trial for Firehawk™ Stent Finishes Last Enrollment - 28 Nov 2022
MicroPort announced that the last patient enrollment for the TARGET IV...MicroPort® Announces Important Follow-up Results at ESC Congress 2022 - 16 Sep 2022
MicroPort® recently participated in the European Society of Cardiology...MicroPort® MedBot™ Listed among "50 Smartest Companies" in MIT Review - 12 Sep 2022
MicroPort® MedBot™ has been named by MIT Technology Review as one of t...Endovastec™ Minos™ Receives Approval for Marketing in Colombia - 02 Sep 2022
Endovastec™ recently received registration approval from the Colombian...MicroPort® Announces 2022 Interim Results - 01 Sep 2022
MicroPort® announced the interim results of the Group and its subsidia...MicroPort EP Listed on the SSE STAR Market - 31 Aug 2022
First innovative medical device company goes public on the STAR Market...CardioFlow Medtech Announces 2022 Interim Results - 30 Aug 2022
CardioFlow Medtech announced the interim results of the Company and it...MicroPort NeuroTech™ Announces 2022 Interim Results - 27 Aug 2022
MicroPort NeuroTech™ today announced the interim results of the Compan...MicroPort NeuroTech™ NUMEN Receives Marketing Approval in Japan - 27 Aug 2022
MicroPort NeuroTech™ has received marketing approval issued by Ministr...MicroPort® MedBot™ Announces 2022 Interim Results - 26 Aug 2022
MicroPort® MedBot™ today announced the interim results of the Company ...Endovastec™ Announces 2022 Interim Results - 25 Aug 2022
Endovastec™ today announced the interim results of the Company and its...MicroPort NeuroTech™ APOLLO™ Completes First Implantation in Brazil - 19 Aug 2022
MicroPort NeuroTech™ recently announced that its independently develop...VitaFlow Liberty™ Obtains Marketing Approval in Colombia - 19 Aug 2022
CardioFlow Medtech recently announced VitaFlow Liberty™ has received m...